Trial intelligence / Profile preview

Losartan for post-dialysis euvolemic hypertension in end-stage renal disease

ACTRN12615001322527Phase 3Active, not recruiting

Sponsor
Universiti Sains Malaysia
Start
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of losartan, sponsored by Universiti Sains Malaysia. Started Dec 2015; status: active, not recruiting.

02

Drugs

losartan

Beyond the preview

Go deeper on ACTRN12615001322527.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12615001322527.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call